Efficacy and safety of sibeprenlimab in IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials
Abstract Background IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. A Proliferation-Inducing Ligand (APRIL) plays a critical role in the development and progression of IgAN. This study aimed to evaluate the efficacy and safety of sibeprenlimab, an APRIL receptor antag...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2026-03-01
|
| Серія: | BMC Nephrology |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12882-026-04927-9 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|